A Study of Telisotuzumab Adizutecan (ABBV-400) in People With Solid Tumor Cancer

Full Title

A Phase 2 Study to Evaluate the Safety and Efficacy of Telisotuzumab Adizutecan for the Treatment of Subjects with Locally Advanced or Metastatic Solid Tumors that Harbor MET Amplification

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Yonina Murciano-Goroff’s office at 646-888-4226.

Protocol

25-360

Phase

Phase II (phase 2)

Disease Status

Relapsed or Refractory

Investigator

Yonina R. Murciano-Goroff

Co-Investigators

James J. Harding

Diseases

Colorectal Cancer
Lung Cancer › Lung Cancer, Non-Small Cell
Solid Tumors
Upper Gastrointestinal › Esophageal Cancer

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT07196644

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description